Ridge Bio Secures $25 Million to Advance Antibody-Drug Conjugates
A new biotechnology company, Ridge Bio, has announced the successful completion of a $25 million seed funding round. This funding aims to enhance the development of antibody-drug conjugates (ADCs) for…